← Eichor
Condition: Solid Organ Transplant Recipients Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Solid Organ Transplant Recipients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Phase N/A · 1 location(s) · University Hospital, Clermont-Ferrand · NCT06986980Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in So
Phase 1 · 1 location(s) · Francisco Hernández Oliveros · NCT06997471Transplantoux Health Evaluation Study
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT02533245Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
Phase N/A · 23 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05234723Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Phase N/A · 27 location(s) · Arkansas Children's Hospital Research Institute · NCT05550298Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive
Phase N/A · 1 location(s) · Tulane University · NCT05159466Factors Affecting Vaccine Prophylaxis Efficacy in Bone Marrow and Solid Organ Transplant Recipients: Impact on Infection
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07473999Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
Phase 3 · 7 location(s) · Women's College Hospital · NCT05955924Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
Phase 4 · 1 location(s) · Tufts Medical Center · NCT05626530Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04579471Study Evaluating the Efficacy and Safety of Artesunate
Phase 2 · 4 location(s) · Amivas Inc. · NCT06853184High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Phase 2 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05947071The Organ Transplant Recipient HPV and Skin Cancer Study
Phase N/A · 3 location(s) · Merete Haedersdal · NCT05284877iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients
NA · 1 location(s) · The Hospital for Sick Children · NCT05968807Biomarkers in Transplant Recipients to Improve Outcomes
Phase N/A · 1 location(s) · University of Pittsburgh · NCT01163578A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and th
Phase 2 · 37 location(s) · GlaxoSmithKline · NCT07092865COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Phase 2 · 3 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06599658Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NA · 1 location(s) · University Hospital, Grenoble · NCT06341543
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.